Big Data in the life sciences sector is now a strategic and operational issue for almost all stakeholders. Capturing, storing, data flow and analysis of information-rich processes affect all aspects of the pharmaceutical and medical device industries but particularly the discovery, research & development stages. The potential for Big Data to drive forward the anticipated era of personalised & precision medicines makes it an essential part of any life science organisation. In order to realise these potential benefits, a strategic shift towards big data and data-driven approaches must be implemented from senior managers and thoroughly rolled-out across the organisation.
5 Events in One:
- Strategic Development in Big Data Management to Enhance R&D
- Leveraging Discovery & Translational Big Data to Enhance Innovation
- Enhancing Decision-Making through Effective Clinical Data Management
- Utilising Big Data to Achieve Real-World Health Outcomes & Patient Insights
- Big Data Infrastructure & System Design
This 2 day forum is the "must attend" event for those senior decision-makers looking to make the shift towards big data and for those looking to improve their implementation of data-driven approaches for their specific departments.
Further information can be found at http://bigdata2014.nextlevelpharma.com/
Request agenda at http://bigdata2014.nextlevelpharma.com/request-agenda or contact me directly for more information.
Anastasia Ratnikova
NextLevel Pharma, Ph: +421 2 3266 0382, Fax: +421 2 3301 0331
anastasiar@nextlevelpharma.com
www.nextlevelpharma.com